These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long term effects of chemoprophylaxis among contacts of lepromatous cases. Results of 8 1/2 years follow-up. Noordeen SK Lepr India; 1977 Oct; 49(4):504-9. PubMed ID: 342824 [No Abstract] [Full Text] [Related]
5. Extended studies on chemoprophylaxis against leprosy. Noordeen SK; Neelan PN Indian J Med Res; 1978 Apr; 67():515-27. PubMed ID: 355134 [No Abstract] [Full Text] [Related]
6. Chemoprophylaxis in leprosy. Br Med J; 1966 May; 1(5498):1252. PubMed ID: 5328408 [No Abstract] [Full Text] [Related]
7. Leprosy in children and its impact on community health. Hazra SK; Ghosh S Indian J Dermatol; 1981 Jan; 26(1):1-7. PubMed ID: 7347315 [No Abstract] [Full Text] [Related]
8. Repository acedapsone in leprosy chemoprophylaxis and treatment. Sloan NR; Worth RM; Jano B; Fasal P; Shepard CC Lancet; 1971 Sep; 2(7723):525-6. PubMed ID: 4105668 [No Abstract] [Full Text] [Related]
9. Acedapsone in the preventive treatment of leprosy. Russell DA; Worth RM; Jano B; Fasal P; Shepard CC Lepr Rev; 1973 Dec; 44(4):192-5. PubMed ID: 4793795 [No Abstract] [Full Text] [Related]
10. Chemoprophylaxis against leprosy with acedapsone. An interim report. Noordeen SK; Neelan PN; Munaf A Lepr India; 1980 Jan; 52(1):97-103. PubMed ID: 6991817 [No Abstract] [Full Text] [Related]
11. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study. Pettit JH; Rees RJ Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958 [No Abstract] [Full Text] [Related]
12. Leprosy in children aged 0-14 years: report of an 11-year control programme. Keller R; Deen RD Lepr Rev; 1985 Sep; 56(3):239-48. PubMed ID: 4058234 [No Abstract] [Full Text] [Related]
13. Primary dapsone-resistant leprosy in Cebu, Philippines. Guinto RS; Cellona RV; Fajardo TT; de la Cruz EC Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):427-30. PubMed ID: 7042607 [TBL] [Abstract][Full Text] [Related]
14. Diamino diphenyl sulfone in leprosy chemoprophylaxis. Sharma DR Indian Pediatr; 1971 May; 8(5):215-6. PubMed ID: 5095253 [No Abstract] [Full Text] [Related]
15. Multidrug therapy for treatment of paucibacillary leprosy in western Kenya--preliminary communications. Orege PA; Obura M; Okelo C; Okuku P; Makokha S; Nyawalo J East Afr Med J; 1990 Sep; 67(9):632-9. PubMed ID: 2253572 [TBL] [Abstract][Full Text] [Related]
16. Leprosy control in Shandong Province, China, 1955-1983; some epidemiological features. Li HY; Pan YL; Wang Y Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):79-85. PubMed ID: 3998564 [TBL] [Abstract][Full Text] [Related]
17. Thirty years of leprosy control work--what next? Dharmendra Lepr India; 1980 Oct; 52(4):566-72. PubMed ID: 7464063 [No Abstract] [Full Text] [Related]
18. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy. Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585 [No Abstract] [Full Text] [Related]
19. Effect of DDS therapy on the acetylcholine sweat function test in fifty cases of tuberculoid and maculoanesthetic leprosy. Yawalkar SJ; Sanjana HB Int J Lepr Other Mycobact Dis; 1974; 42(1):55-7. PubMed ID: 4472091 [No Abstract] [Full Text] [Related]
20. [Study on prevention of leprosy. 2. Chemo-prophylaxis trial for leprosy household contact children]. Saikawa K Nihon Rai Gakkai Zasshi; 1985; 54(4):187-92. PubMed ID: 3842969 [No Abstract] [Full Text] [Related] [Next] [New Search]